Article
Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Neuropharmacology - 1 May 2017
Browne Caroline A, Erickson Rebecca L, Blendy Julie A, Lucki Irwin
Abstract excerpt
Pharmacogenetic studies have identified the non-synonymous single nucleotide polymorphism (A118G) in the human mu opioid receptor (MOR) gene (OPRM1) as a critical genetic variant capable of altering the efficacy of opioid therapeutics. To date few studies have explored the potential impact of the OPRM1 A118G polymorphism on the pharmacological effects of buprenorphine (BPN), a potent MOR partial agonist and kappa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
